Viewpoints

The Latest

Is PrEP 100 % Effective or 100 % Over-Hyped?

While we should be excited over zero HIV infections at Kaiser San Francisco's PrEP program, there are also some important counterpoints to note, explains Tim Lahey, M.D., M.M.Sc.

By Tim Lahey, M.D., M.M.Sc.

We're in an HIV Prevention Revolution. Where Is the Excitement? A Blog Entry by Marc-André LeBlanc

Why aren't these new prevention strategies being shouted from the rooftops of more organizations that serve gay men? Part of the reason is that service providers are grappling with the rapidly changing HIV prevention landscape.

By Marc-André LeBlanc for Canadian AIDS Treatment Information Exchange

Top 10 Things Public Health Practitioners, Government Policymakers and Community Advocates Need to Do to Move to the End of HIV and HCV

When NASTAD Executive Director Murray Penner spoke at the closing plenary of the HIV Forum for Collaborative HIV Research National Summit, he stressed that, despite considerable progress against the dual epidemics of HIV and HCV, challenges remain --...

By Murray Penner for National Alliance of State and Territorial AIDS Directors

Advocates for Women Talk About CROI 2015

A webinar co-sponsored by The Well Project, Positive Women's Network-USA and TheBody.com/TheBodyPRO.com draws attention to data of interest to women with HIV, their care providers and those interested in HIV prevention for women.

By Barbara Jungwirth

HIV Conspiracy Theories and the Black Community: A Blog Entry by Kimberly A. Parker, Ph.D.

A new study finds that the distrust brought about by HIV-related rumors and conspiracy theories could be addressed by strengthening relationships between African Americans and health professionals. Dr. Kimberly Parker adds that it's important to ackn...

By Kimberly A. Parker, Ph.D.

The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies

Gilead has devised a strategy to extract maximum profits, suggests policy analyst Brook Baker. He urges us not to blame governments and force taxpayers to create more pharmaceutical wealth, and instead calls for action to ensure access for all at an ...

By Brook K. Baker

My Wishes for HIV and Health Care Reform in 2015

What does an HIV care advocate think about during a new year's smooch? Health care reform, of course! John Peller of AIDS Foundation of Chicago and HIVHealthReform.org shares his top five wishes for improving Obamacare in 2015.

By John Peller

What Does 2015 Hold in Store for HIV Research?

While current HIV treatment allows patients to live long, healthy lives, there are still concerns over tolerability, adherence, quality of life, as well as prevention. Therefore, we asked some of the leading HIV experts what research they’re most looki…

By Myles Helfand and Theo Smart

A Chat With Jim Pickett as the First HIV Research for Prevention (HIV R4P) Conference Looms

The biennial microbicide conference and the annual vaccine conference are coming together and sharing space for a unified conference on new prevention technologies.

By JD Davids

The Viral Divide and the HIV Prevention Landscape

Inside the "viral divide," an invisible chasm between those who are HIV negative and those who are HIV positive are concerns about priorities, resources, sexuality and what it means to be a community, explains Rodriguez.

By Mathew Rodriguez